Wei‐Ming Su

522 total citations
25 papers, 255 citations indexed

About

Wei‐Ming Su is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Wei‐Ming Su has authored 25 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Neurology, 9 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Wei‐Ming Su's work include Amyotrophic Lateral Sclerosis Research (11 papers), Neurogenetic and Muscular Disorders Research (7 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Wei‐Ming Su is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (11 papers), Neurogenetic and Muscular Disorders Research (7 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Wei‐Ming Su collaborates with scholars based in China and United States. Wei‐Ming Su's co-authors include Qing‐Qing Duan, Xiaojing Gu, Zheng Jiang, Bei Cao, Yi Wang, Yongping Chen, Huifang Shang, Yangfan Cheng, Tianmi Yang and Guo‐Bo Li and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, BMC Medicine and Frontiers in Pharmacology.

In The Last Decade

Wei‐Ming Su

22 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Ming Su China 9 104 89 61 33 32 25 255
Fangfang Hu China 13 131 1.3× 79 0.9× 54 0.9× 28 0.8× 42 1.3× 27 315
Sali M.K. Farhan Canada 12 77 0.7× 221 2.5× 43 0.7× 32 1.0× 47 1.5× 33 368
Hyeonjoo Im South Korea 5 98 0.9× 168 1.9× 46 0.8× 57 1.7× 98 3.1× 8 348
C. Heimburger France 8 40 0.4× 79 0.9× 33 0.5× 26 0.8× 37 1.2× 22 322
Michelle M. Mezei Canada 10 158 1.5× 165 1.9× 76 1.2× 35 1.1× 25 0.8× 19 326
Jana Švarcová Czechia 12 117 1.1× 75 0.8× 28 0.5× 74 2.2× 124 3.9× 20 385
Christine Makowski Germany 10 95 0.9× 229 2.6× 31 0.5× 24 0.7× 51 1.6× 18 480
Christina B. Schroeter Germany 13 72 0.7× 118 1.3× 17 0.3× 52 1.6× 43 1.3× 29 307
Arum Yoo South Korea 11 43 0.4× 147 1.7× 40 0.7× 74 2.2× 27 0.8× 13 284
Anna Marcé‐Grau Spain 10 77 0.7× 139 1.6× 12 0.2× 19 0.6× 20 0.6× 19 284

Countries citing papers authored by Wei‐Ming Su

Since Specialization
Citations

This map shows the geographic impact of Wei‐Ming Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ming Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ming Su more than expected).

Fields of papers citing papers by Wei‐Ming Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Ming Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ming Su. The network helps show where Wei‐Ming Su may publish in the future.

Co-authorship network of co-authors of Wei‐Ming Su

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Ming Su. A scholar is included among the top collaborators of Wei‐Ming Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Ming Su. Wei‐Ming Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duan, Qing‐Qing, Wei‐Ming Su, Xiaojing Gu, et al.. (2025). Genetically Predict Diet‐derived Antioxidants and Risk of Neurodegenerative Diseases Among Individuals of European Descent: A Mendelian Randomization Study. Brain and Behavior. 15(8). e70766–e70766.
2.
He, Shixu, Wei‐Ming Su, Qing‐Qing Duan, et al.. (2025). Viral infections and the risk of neurodegenerative diseases: a comprehensive meta-analysis and systematic review. Translational Psychiatry. 15(1). 388–388.
3.
Chen, Ting, Xiaojing Gu, Wei‐Ming Su, et al.. (2024). Systematic druggable genome‐wide Mendelian randomization identifies therapeutic targets for sarcopenia. Journal of Cachexia Sarcopenia and Muscle. 15(4). 1324–1334. 15 indexed citations
4.
Gu, Xiaojing, Wei‐Ming Su, Ting Chen, et al.. (2024). Causal association and mediating effect of blood biochemical metabolic traits and brain image-derived endophenotypes on Alzheimer's disease. Heliyon. 10(8). e27422–e27422. 1 indexed citations
5.
He, Shixu, Wei‐Ming Su, Qing‐Qing Duan, et al.. (2024). Quantifying the split-elbow sign: a comprehensive study in amyotrophic lateral sclerosis. Frontiers in Neurology. 15. 1499668–1499668.
6.
Chen, Ting, et al.. (2024). Identification of Potential Causal Genes for Neurodegenerative Diseases by Mitochondria-Related Genome-Wide Mendelian Randomization. Molecular Neurobiology. 62(3). 3892–3902. 5 indexed citations
7.
Jiang, Zheng, Xiaojing Gu, Wei‐Ming Su, et al.. (2024). Discovery and Exploration of Lipid-Modifying Drug Targets for ALS by Mendelian Randomization. Molecular Neurobiology. 61(9). 6572–6583. 3 indexed citations
8.
Su, Wei‐Ming, et al.. (2024). Non-genetic risk factors of Parkinson’s disease: A large meta-analysis and systematic review. Chinese Medical Journal. 137(15). 1873–1875. 1 indexed citations
9.
Duan, Qing‐Qing, Zheng Jiang, Wei‐Ming Su, et al.. (2023). Risk factors of amyotrophic lateral sclerosis: a global meta-summary. Frontiers in Neuroscience. 17. 1177431–1177431. 14 indexed citations
10.
Gu, Xiaojing, Wei‐Ming Su, Qing‐Qing Duan, et al.. (2023). Expanding causal genes for Parkinson’s disease via multi-omics analysis. npj Parkinson s Disease. 9(1). 20 indexed citations
11.
Gu, Xiaojing, Wei‐Ming Su, Zheng Jiang, et al.. (2023). Identifying novel genes for amyotrophic lateral sclerosis by integrating human brain proteomes with genome-wide association data. Journal of Neurology. 270(8). 4013–4023. 4 indexed citations
12.
Su, Wei‐Ming, Xiaojing Gu, Qing‐Qing Duan, et al.. (2023). Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease. Journal of Neurology Neurosurgery & Psychiatry. 94(11). 954–961. 70 indexed citations
13.
Jiang, Zheng, Xiaojing Gu, Wei‐Ming Su, et al.. (2023). Protective effect of antihypertensive drugs on the risk of Parkinson’s disease lacks causal evidence from mendelian randomization. Frontiers in Pharmacology. 14. 1107248–1107248. 4 indexed citations
14.
Gu, Xiaojing, Wei‐Ming Su, Qing‐Qing Duan, et al.. (2022). Production of a human iPSC line from an early-onset Parkinson’s disease patient with a novel CHCHD2 gene truncated mutation. Stem Cell Research. 64. 102881–102881. 2 indexed citations
15.
Gu, Xiaojing, Wei‐Ming Su, Zheng Jiang, et al.. (2022). Identifying novel proteins underlying schizophrenia via integrating pQTLs of the plasma, CSF, and brain with GWAS summary data. BMC Medicine. 20(1). 474–474. 9 indexed citations
16.
Su, Wei‐Ming, Xiaojing Gu, Qing‐Qing Duan, et al.. (2022). Genetic factors for survival in amyotrophic lateral sclerosis: an integrated approach combining a systematic review, pairwise and network meta-analysis. BMC Medicine. 20(1). 209–209. 8 indexed citations
17.
Su, Wei‐Ming, Xiaojing Gu, Yanbing Hou, et al.. (2021). Association Analysis of WNT3, HLA-DRB5 and IL1R2 Polymorphisms in Chinese Patients With Parkinson’s Disease and Multiple System Atrophy. Frontiers in Genetics. 12. 765833–765833. 5 indexed citations
18.
Su, Wei‐Ming, Yangfan Cheng, Zheng Jiang, et al.. (2021). Predictors of survival in patients with amyotrophic lateral sclerosis: A large meta-analysis. EBioMedicine. 74. 103732–103732. 52 indexed citations
19.
Chen, Qu, et al.. (2021). Neutrophil-to-Lymphocyte Ratio Facilitates Identification of Obstructive Sleep Apnea in Patients with Type B Aortic Dissection. Canadian Respiratory Journal. 2021. 1–10. 3 indexed citations
20.
Lin, Yijian, et al.. (2020). Value of circular RNA 0007385 in disease monitoring and prognosis estimation in non–small‐cell lung cancer patients. Journal of Clinical Laboratory Analysis. 34(8). 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fangfang Hu Breakdown of academic impact, for papers by Sali M.K. Farhan Breakdown of academic impact, for papers by Hyeonjoo Im Breakdown of academic impact, for papers by C. Heimburger Breakdown of academic impact, for papers by Michelle M. Mezei Breakdown of academic impact, for papers by Jana Švarcová Breakdown of academic impact, for papers by Christine Makowski Breakdown of academic impact, for papers by Christina B. Schroeter Breakdown of academic impact, for papers by Arum Yoo Breakdown of academic impact, for papers by Anna Marcé‐Grau
Rankless by CCL
2026